Travere Therapeutics Inc
For the period ended Dec 31, 2023. Filed Feb 20, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 20, 2024
TVTX$51.63+4.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
We lease the following locations to conduct our business:
| Location | Address | Lease Expiration | Square Feet |
|---|---|---|---|
| San Diego, California | 3611 Valley Centre Drive, Suite 300 | August 31, 2028 | 103,677 |
| Dublin, Ireland | 3 Mount Street Crescent, 2nd Floor | September 30, 2027 | 1,960 |
We believe these facilities are adequate to conduct our business.
For additional information regarding our lease agreements, see Note 18 of the Consolidated Financial Statements included in this report.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.